Protocol No.: S1900E

A Phase II Study of AMG 510 in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNGMAP Sub-Study)
Principal Investigator
Almubarak, Mohammed
Phase
II
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Carla Ross, RN
Senior Research Nurse
Phone: +1 304-293-2633

View on ClinicalTrials.gov